Paul DaSilva‐Jardine

An EP2 receptor-selective prostaglandin E ₂ agonist induces bone healing

Vishwas Paralkar, Fran Borovečki, H.Z. Ke et al. · Proceedings of the National Academy of Sciences · 2003 · 186 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models

Hua Zhu Ke, Vishwas Paralkar, W A Grasser et al. · Endocrinology · 1998 · 158 citations

Life Sciences, Endocrinology, Pharmacology +17

Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production

Manon Viaud, Stoyan Ivanov, Nemanja Vujić et al. · Circulation Research · 2018 · 136 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Discovery of (<i>S</i>)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus

Jeffrey A. Pfefferkorn, Angel Guzmán-Pérez, John Litchfield et al. · Journal of Medicinal Chemistry · 2011 · 115 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels

Sumeet A. Khetarpal, Xuemei Zeng, John S. Millar et al. · Nature Medicine · 2017 · 112 citations · Full text

Life Sciences, Cardiology, Molecular Genetics +15